NDC 73309-242-01 - Griseofulvin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73309-242
- Requested NDC
- 73309-242-01
- Package NDCs from labels
- 73309-242-01, 73309-242-04, 73309-242-02, 73309-242-03
- Manufacturer
- BLUEBAY SHANDONG CO.,LTD
- Effective date
- 2022-03-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Griseofulvin - BLUEBAY SHANDONG CO.,LTD | BLUEBAY SHANDONG CO.,LTD | 2022-03-28 | BULK INGREDIENT - ANIMAL DRUG |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73309-242-01 | Griseofulvin | 25 kg in 1 DRUM | POWDER | 25 | 3 | |
| 73309-242-02 | Griseofulvin | 1 kg in 1 JAR | POWDER | 1 | 3 | |
| 73309-242-03 | Griseofulvin | 20 kg in 1 DRUM | POWDER | 20 | 3 | |
| 73309-242-04 | Griseofulvin | 5 kg in 1 DRUM | POWDER | 5 | 3 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ultramicrosize Griseofulvin | ULTRAMICROSIZE GRISEOFULVIN TABLETS | Amneal Pharmaceuticals of New York LLC | f21314eb-3581-4e06-9fe7-8239cc80ba11 | 2025-12-20 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Ultramicrosize Griseofulvin | GRISEOFULVIN | Chartwell RX, LLC. | efb8a660-802c-4ca6-bbff-ad7b48b91aef | 2025-12-10 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Ultramicrosize Griseofulvin | GRISEOFULVIN | Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | ae369582-2e4c-48a4-ac42-0a77466654fd | 2025-11-06 | Warnings, Adverse reactions | 32HRV3E3D5 |
| GRISEOFULVIN MICROSIZE | GRISEOFULVIN | Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc | 1c26d7a6-17d9-4a95-a4ee-cfc5fe6bb95d | 2025-11-04 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Ultramicrosize Griseofulvin | ULTRAMICROSIZE GRISEOFULVIN | Sandoz Inc | f4fa0eb9-bd6a-4ea2-b565-e0db88aa1ebd | 2025-05-14 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Griseofulvin | GRISEOFULVIN | Sandoz Inc | 98829d90-b289-4bec-a625-7af412a5cb2d | 2025-05-14 | Warnings, Adverse reactions | 32HRV3E3D5 |
| ULTRAMICROSIZE GRISEOFULVIN | ULTRAMICROSIZE GRISEOFULVIN | Chartwell RX, LLC | 640c489e-f491-4805-a390-ef4be43e261b | 2025-02-20 | Warnings, Adverse reactions | 32HRV3E3D5 |
| ULTRAMICROSIZE GRISEOFULVIN | ULTRAMICROSIZE GRISEOFULVIN | Ayurax, LLC. | 43fc5201-d23c-4d83-9247-baefe03774ef | 2025-02-03 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Griseofulvin | GRISEOFULVIN | Cosette Pharmaceuticals, Inc. | 67e3ba3c-77e1-43b5-a93c-5bf5e3855780 | 2024-12-02 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Griseofulvin | GRISEOFULVIN (MICROSIZE) | Chartwell RX, LLC. | 9f7e4ecf-f992-42c5-81ea-91e6587b22a5 | 2024-10-28 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Griseofulvin MICROSIZE | GRISEOFULVIN | Chartwell RX, LLC. | 6902a976-b0c5-48a4-8d50-984002be6c3a | 2024-10-28 | Warnings, Adverse reactions | 32HRV3E3D5 |
| grisofulvin | GRISOFULVIN | Cipla USA Inc. | d5c737e5-51b8-4322-a2a5-4d4a392c1f56 | 2024-03-27 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Griseofulvin | GRISEOFULVIN | Actavis Pharma, Inc. | af318d5d-cc39-4a63-a590-b87c50f2694f | 2023-09-30 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Griseofulvin | GRISEOFULVIN | Sigmapharm Laboratories, LLC | 5bafb97f-621b-4b96-a787-68e0bb5c8637 | 2022-09-14 | Warnings, Adverse reactions | 32HRV3E3D5 |
| Ultramicrosize Griseofulvin | ULTRAMICROSIZE GRISEOFULVIN | Sigmapharm Laboratories, LLC | 37b4d132-84f1-4394-b468-7e74eeec61eb | 2022-01-14 | Warnings, Adverse reactions | 32HRV3E3D5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.